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Letters to the EditorAngeborenen Herzkrankheiten, a book
and systematic review of embryology
that included congenital cardiac anom-
alies. One of the sections was entitled,
‘‘Incomplete Division and Unilateral
Transformation of a Primary Truncus.
Persistence of the Truncus Arterio-
sus—Presence of Only One Single
Major Arterial Vessel.’’3 In this sec-
tion, he used descriptors for the com-
mon arterial trunk similar to those
presented in the article by Russell and
colleagues.1 This simplified approach
was discussed by Calder and associ-
ates4 and emphasized by Jacobs,5 as in-
dicated in Russell and colleagues’
article,1 but had initially been
presented almost a century before.
Vierordt’s original classification was
also discussed on page 1250 of the
seminal work by Collette and Ed-
wards.6 Vierordt3 reviewed 40 cases
(including some of Rokitansky’s origi-
nal preparations) and proposed 3 cate-
gories: (1) ‘‘partial persistence of an
embryonic truncus arteriosus: one ma-
jor vessel from which arises an aorta
and pulmonary artery’’; (2) ‘‘a single
major vessel arising from the heart of
the character of an aorta with more or
less typical branching of the same,
lacking a pulmonary artery as such,
and the pulmonary vessels arise from
the main arterial vessel’’; and (3) ‘‘a
single vessel of the character of a pul-
monary artery.’’ It is also ironic that
Vierordt3 states before presenting his
3 categories, ‘‘It would be highly desir-
able that there would be agreement in
the nomenclature.’’ He pointed out
how useful this would be for better def-
inition of these types of lesions. It
seems that we have come full circle
in the description and categorization
of the common arterial trunk and
have rediscovered the original classifi-
cation of these lesions and a plea for
common nomenclature. We would
like to recognize the initial classifica-
tion and echo the plea of Vierordt3 by
encouraging the adoption of this sim-
ple categorization presented recently
by Russell and colleagues1 and real-
ized by others before them.3-6The JournalLance K. Erickson,
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We appreciate the letter from Erick-
son andOpitz in support of our catego-
rization of common arterial trunk as
either aortic or pulmonary dominant.1
We are intrigued that they have brought
to our attention the work of Vierordt2
published more than 100 years ago.
Although his theme was similar, there
are important differences that we be-
lieve deserve emphasis.
As we understood Vierordt’s cate-
gorization,2 he distinguished between
a common arterial trunk, a solitary
aorta, and a solitary pulmonary trunk.
Although this is similar to our con-
cept, our suggestion is that common
arterial trunk itself, according to
its pattern of branching, is bestof Thoracic and Cardiovascular Surgersubdivided on the basis of aortic or
pulmonary dominance. The semantics
are important. Our emphasis on this
particular categorization is related to
the accepted definition of common ar-
terial trunk: a solitary trunk that exits
the heart through a common ventricu-
loarterial junction and supplies di-
rectly the systemic, pulmonary, and
coronary arterial pathways. A solitary
aorta, such as exists in tetralogy with
pulmonary atresia andmajor aortopul-
monary collateral arteries (historically
and erroneously labeled ‘‘pseudotrun-
cus’’), does not fit this definition. A
solitary pulmonary artery, such as
seen in hypoplastic left heart syn-
drome with aortic atresia, also does
not fit this definition. Thus our inter-
pretation of Vierordt’s analysis2 is
somewhat different than that of Erick-
son and Opitz.
We support Erickson and Opitz in
their acknowledgement of the works
of Vierordt,2 Calder and associates,3
Van Praagh and Van Praagh,4 Jacobs,5
and Collette and Edwards6 in arriving
at what we consider to be the optimal
approach to categorization of com-
mon arterial trunk.
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SURGERY: CAUTION ADVISED
To the Editor:
We recently read the interesting
study by McKellar and associates1
evaluating the effectiveness of dabiga-
tran for thromboprophylaxis after im-
plantation of mechanical heart valves.
Using a heterotopic aortic valvemodel,
the authors randomized 30 swine to
receive dabigatran, enoxaparin, or no
anticoagulation after implantation of
a mechanical valve conduit. At 30
days, McKellar and associates1 re-
ported that dabigatran reduced throm-
bus and platelet deposition on the
mechanical valve leaflets without an
increase in adverse events.
Several new oral direct thrombin in-
hibitors are being evaluated as alterna-
tives for long-term anticoagulation
because of the widely known difficul-
ties associatedwithwarfarin, including
its long half-life and unpredictable
dose response. Compared with warfa-
rin, dabigatran has no food or drug in-
teractions, has a rapid onset of action,
and does not require blood monitor-
ing.2,3 Paradoxically, while lauded for
its ease of use, the management of
patients receiving dabigatran may be
extremely challenging in the setting
of active bleeding and coagulopathy.
McKellar and colleagues1 claim that,
in contrast to warfarin, dabigatran
‘‘could prove safer should emergency
surgery be needed.’’ We respectfully
disagree with this statement. There is
no known antidote available for dabi-
gatran. Vitamin K and fresh frozen
plasma are ineffective, and dialysis
maybe the onlymeans available to rap-
idly reverse the anticoagulant effects of
dabigatran.4,5
We recently prescribed dabigatran
to a 74-year-old woman after coronary1288 The Journal of Thoracic andartery bypass graft surgery. The pa-
tient had a history of atrial fibrillation
and had previously refused warfarin
therapy. After surgery, she continued
to refuse warfarin, but she agreed to
take dabigatran to reduce the risk of
stroke and systemic embolism.6 Dabi-
gatran was initiated on postoperative
day 3 using the lowest possible dose
(75mg twice daily), given the patient’s
frailty and mild renal insufficiency.
She was monitored in the hospital for
6 additional days before transfer to
a rehabilitation facility. A chest x-ray
film before discharge noted a very
small left pleural effusion. Twodays af-
ter transfer, the patient returned to hos-
pital with a massive left hemothorax
and gastrointestinal bleeding. She was
treated with intubation for respiratory
distress and placement of a left thora-
costomy tube, draining more than 2 L
of blood. The patient had evidence of
a severe coagulopathy, with an interna-
tional normalized ratio of 21.5 and
a partial thromboplastin time of 161.2.
Tomanage the bleeding, we instituted
emergency dialysis, successfully cor-
recting the coagulopathy. After 2 di-
alysis treatments, the international
normalized ratio and partial thrombo-
plastin time were reduced to 1.9 and
47.4, respectively, and the chest and
gastrointestinal bleeding had sub-
sided. The patient made a miraculous
recovery and was discharged back to
rehabilitation 2 weeks later without
anticoagulation therapy.
McKellar and associates1 are to be
congratulated for their novel study.
Their animal model data suggest that
dabigatran may have a role in the
thromboprophylaxis of mechanical
valves. Wewould be intrigued to learn
whether they have had any clinical ex-
perience using dabigatran in patients
undergoing cardiac surgery, either
for the thromboprophylaxis of me-
chanical valves or for the anticoagula-
tion of atrial fibrillation. Although our
experience is limited to a single case,
the outcome was nearly fatal. We
would therefore strongly advise cau-
tion when prescribing dabigatranCardiovascular Surgery c November 20early after cardiac surgery, at least un-
til additional clinical experience
accrues.
Alexander Kulik, MD, MPHa,b
Mark B. Saltzman, MDa
James J. Morris, MDa,b
aLynn Heart and Vascular Institute
Boca Raton Regional Hospital
Boca Raton, Fla
bCharles E. Schmidt College of
Medicine
Florida Atlantic University
Boca Raton, FlaReferences
1. McKellar SH, Abel S, Camp CL, Suri RM,
Ereth MH, Schaff HV. Effectiveness of dabigatran
etexilate for thromboprophylaxis of mechanical
heart valves. J Thorac Cardiovasc Surg. 2011;
141:1410-6.
2. Stangier J. Clinical pharmacokinetics and pharma-
codynamics of the oral direct thrombin inhibitor da-
bigatran etexilate. Clin Pharmacokinet. 2008;47:
285-95.
3. Francis CW. New issues in oral anticoagulants. He-
matology Am Soc Hematol Educ Program.
2008;259-65.
4. van Ryn J, Stangier J, Haertter S, Liesenfeld KH,
Wienen W, Feuring M, et al. Dabigatran etexi-
late—a novel, reversible, oral direct thrombin in-
hibitor: interpretation of coagulation assays and
reversal of anticoagulant activity. Thromb Haemost.
2010;103:1116-27.
5. Lee CJ, Ansell JE. Direct Thrombin Inhibitors. Br J
Clin Pharmacol. 2011 Jan 17 [Epub ahead of print].
6. Connolly SJ, EzekowitzMD, Yusuf S, Eikelboom J,
Oldgren J, Parekh A, et al. Dabigatran versus war-
farin in patients with atrial fibrillation. N Engl J
Med. 2009;361:1139-51.
doi:10.1016/j.jtcvs.2011.05.029DOUBLE RIGHT CORONARY
ARTERY OR CONUS ARTERY
WITH SEPARATE ORIFICE?
To the Editor:
In their recent Cardiothoracic Im-
aging article, Chen, Chien, and Lee1
have applied the term ‘‘double right
coronary artery’’1 (RCA) in a debat-
able way.
The anatomic nomenclature for the
situation they have described has
been better termed ‘‘the conus artery:
a third coronary artery’’2; ‘‘conus cor-
onary artery with aortic origin’’3; or,
more appropriately, ‘‘conus artery
with separate orifice,’’ coded as11
